New Risk • Jun 05
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 11% per year over the past 5 years. Minor Risk Market cap is less than US$100m (US$20.8m market cap). Reported Earnings • May 17
First quarter 2026 earnings released: US$0.41 loss per share (vs US$0.52 loss in 1Q 2025) First quarter 2026 results: US$0.41 loss per share (improved from US$0.52 loss in 1Q 2025). Revenue: US$9.86m (down 32% from 1Q 2025). Net loss: US$1.12m (loss narrowed 17% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings. 공시 • May 15
NextPlat Corp has filed a Follow-on Equity Offering in the amount of $3.738706 million. NextPlat Corp has filed a Follow-on Equity Offering in the amount of $3.738706 million.
Security Name: Common Stock
Security Type: Common Stock
Transaction Features: At the Market Offering 공시 • May 07
NextPlat Corp to Report Q1, 2026 Results on May 14, 2026 NextPlat Corp announced that they will report Q1, 2026 results Pre-Market on May 14, 2026 공시 • May 04
NextPlat Corp, Annual General Meeting, Jun 24, 2026 NextPlat Corp, Annual General Meeting, Jun 24, 2026. 공시 • Apr 29
NextPlat Corp Regains Compliance With Nasdaq Bid Price Requirement As previously disclosed, on April 28, 2025, NextPlat Corp. received a written notice (the Notice) from the Listing Qualifications Department (the Staff) of The Nasdaq Stock Market LLC (Nasdaq) notifying the Company that, because the closing bid price for the Company's common stock, par value $0.0001 per share (the Common Stock), closed below $1.00 per share for 30 consecutive trading days, the Company no longer met the minimum bid price requirement for continued inclusion on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the Bid Price Requirement). On October 28, 2025, the Company received a letter from the Staff notifying that the Company is eligible for a second 180-day period, or until April 27, 2026 (the Second Grace Period) to regain compliance with the Bid Price Requirement. On April 27, 2026, the Company was notified by Nasdaq that the Company has regained compliance with the Bid Price Requirement and that this matter is now closed. Nasdaq has since determined that, for the last 10 consecutive business days, from April 13, 2026 to April 24, 2026, the closing bid price of the Company's shares has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2). With Nasdaq's confirmation of compliance, NextPlat remains listed on The Nasdaq Capital Market. 공시 • Apr 18
NextPlat Corp announces its PharmcoRx subsidiary Deploys Artificial Intelligence-Powered Prescription Processing Technology NextPlat Corp. announced that its PharmcoRx subsidiary has deployed artificial intelligence (AI)-powered prescription in-take and processing technology into its pharmacy management system. This AI technology will support PharmcoRx as it seeks to improve the efficiency of its medication fulfillment processes as it expands the scale and scope of its offerings. To provide improved prescription management and fulfilment services to customers while scaling to meet the anticipated growth in new contracted clients, the AI-powered software tools enable the rapid automation of previously manual processes including pharmacy data entry, faxing and refill management, creating fully-HIPAA compliant digital workflows. The AI software is being provided by an established pharmacy technology software vendor with a large installed base of clients in the U.S. and Canada and is undergoing capability enhancements led by PharmcoRx's internal digital transformation team. The enhanced AI software is expected to drive significant efficiency gains and cost reductions across the Company's pharmacy operations. The adoption of AI technology has been an important part of NextPlat's ongoing efforts to improve internal operational efficiencies and has been integrated into its recently upgraded ClearMetrX 4.0, the Company's next generation, proprietary healthcare data analytics and reporting software platform. ClearMetrX 4.0 has now been deployed internally and is currently undergoing beta testing by current clients. Reported Earnings • Apr 05
Full year 2025 earnings released: US$0.44 loss per share (vs US$0.68 loss in FY 2024) Full year 2025 results: US$0.44 loss per share (improved from US$0.68 loss in FY 2024). Revenue: US$54.3m (down 17% from FY 2024). Net loss: US$11.7m (loss narrowed 17% from FY 2024). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 39% per year, which means it is significantly lagging earnings. 공시 • Apr 01
NextPlat Corp Announces Reverse Stock Split to Regain Compliance with Nasdaq's Bid Price Requirement NextPlat Corp. announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company's issued and outstanding common stock. The reverse stock split is expected to become effective at 12:01 a.m. Eastern Time on April 6, 2026, with trading on a split-adjusted basis beginning on The Nasdaq Capital Market upon the commencement of trading on April 7, 2026 under the Company's existing ticker symbol. The reverse stock split was previously approved by the Company's stockholders at the special meeting of stockholders held on March 27, 2026, which authorized the Board of Directors to implement a reverse split. The Board determined that implementing the reverse split at this time is appropriate to regain compliance with the minimum bid price requirement for maintaining the listing of the Company's common stock on The Nasdaq Capital Market and to broaden potential investor interest. New Risk • Mar 27
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (US$14.6m market cap). 공시 • Mar 25
NextPlat Corp to Report Fiscal Year 2025 Results on Mar 31, 2026 NextPlat Corp announced that they will report fiscal year 2025 results on Mar 31, 2026 Reported Earnings • Nov 16
Third quarter 2025 earnings released: US$0.084 loss per share (vs US$0.22 loss in 3Q 2024) Third quarter 2025 results: US$0.084 loss per share (improved from US$0.22 loss in 3Q 2024). Revenue: US$13.8m (down 11% from 3Q 2024). Net loss: US$2.19m (loss narrowed 48% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings. 공시 • Oct 31
NextPlat Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement NextPlat Corp. announced that it has received an additional 180-calendar-day extension from the Nasdaq Stock Market (“Nasdaq”) to regain compliance with the minimum bid price requirement, as outlined in Nasdaq Listing Rule 5550(a)(2). The Company now has until April 27, 2026, to meet the requirement for its shares of common stock to maintain a closing bid price of at least USD 1.00 per share for a minimum of ten consecutive business days. Nasdaq's extension notice has no immediate effect on the continued listing status of the Company's common stock on The Nasdaq Capital Market LLC under the symbol "NXPL". If at any time during the additional 180-day extension, the bid price of the Company's common stock closes at, or above, $1.00 per share for a minimum of ten consecutive business days, the Nasdaq staff will provide the Company with a written confirmation of compliance and the matter will be closed. Nasdaq granted the extension after determining that NextPlat continues to meet all other continued listing criteria for the Nasdaq Capital Market and the Company has provided written notice of its intention to cure the deficiency within the extension period, if necessary, through a reverse stock split. If the Company does not meet the minimum bid requirement during the additional 180-day extension, Nasdaq will provide written notification to the Company that its common stock will be subject to delisting. At such time, the Company may appeal the delisting determination to a Nasdaq Hearings Panel (the "Panel"). The Company would remain listed pending the Panel's decision. There can be no assurance that if the Company does appeal a subsequent delisting determination, that such appeal would be successful. NextPlat remains committed to full compliance with all Nasdaq listing requirements and will continue to monitor its share price closely. The Company plans to take all necessary actions within the prescribed period to regain compliance. 공시 • Oct 14
NextPlat Corp Announces CFO Changes NextPlat Corp. announced the promotion of Amanda L. Ferrio to the position of Chief Financial Officer, replacing Cecile Munnik, CPA/CA who has decided to depart the Company following completion of a transition period including the filing of the Company's quarterly report for the period ended September 30, 2025. Ms. Ferrio has over 15 years of accounting and finance experience at both Nasdaq-listed and private companies, most recently serving as Vice President of Accounting & Finance at Progressive Care LLC ("Progressive Care"), the Company's healthcare operation it acquired last year. Over the past three years at Progressive Care, Ms. Ferrio oversaw aspects of the accounting department including financial reporting and analysis, budgeting, and forecasting, and managed its SEC filings. Prior to joining Progressive Care, Ms. Ferrio held multiple accounting and finance roles including serving as Controller at BBC International, LLC; Senior Manager, Financial Reporting & Compliance at Willis-Lease Finance Corporation; Senior Accountant, BioMatrix Specialty Pharmacy, and Senior Accountant at FedNat. Ms. Ferrio holds a Master of Science and a Bachelor of Science in Accounting. 공시 • Oct 08
NextPlat Corp to Report Q3, 2025 Results on Nov 14, 2025 NextPlat Corp announced that they will report Q3, 2025 results at 9:30 AM, US Eastern Standard Time on Nov 14, 2025 Reported Earnings • Aug 15
Second quarter 2025 earnings released: US$0.069 loss per share (vs US$0.28 loss in 2Q 2024) Second quarter 2025 results: US$0.069 loss per share (improved from US$0.28 loss in 2Q 2024). Revenue: US$13.2m (down 22% from 2Q 2024). Net loss: US$1.79m (loss narrowed 66% from 2Q 2024). Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings. 공시 • Aug 06
NextPlat Corp to Report Q2, 2025 Results on Aug 14, 2025 NextPlat Corp announced that they will report Q2, 2025 results Pre-Market on Aug 14, 2025 Reported Earnings • May 15
First quarter 2025 earnings released: US$0.052 loss per share (vs US$0.079 loss in 1Q 2024) First quarter 2025 results: US$0.052 loss per share (improved from US$0.079 loss in 1Q 2024). Revenue: US$14.5m (down 17% from 1Q 2024). Net loss: US$1.34m (loss narrowed 9.3% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has fallen by 32% per year, which means it is significantly lagging earnings. 공시 • May 06
NextPlat Corp to Report Q1, 2025 Results on May 15, 2025 NextPlat Corp announced that they will report Q1, 2025 results Pre-Market on May 15, 2025 공시 • Apr 07
NextPlat Corp, Annual General Meeting, Jun 25, 2025 NextPlat Corp, Annual General Meeting, Jun 25, 2025. Location: 3250 mary st., suite 410, coconut grove, fl 33133., United States Reported Earnings • Mar 24
Full year 2024 earnings released: US$0.68 loss per share (vs US$0.22 loss in FY 2023) Full year 2024 results: US$0.68 loss per share (further deteriorated from US$0.22 loss in FY 2023). Revenue: US$65.5m (up 73% from FY 2023). Net loss: US$14.0m (loss widened 271% from FY 2023). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings. 공시 • Mar 06
NextPlat Corp to Report Q4, 2024 Results on Mar 17, 2025 NextPlat Corp announced that they will report Q4, 2024 results Pre-Market on Mar 17, 2025 New Risk • Jan 16
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 39% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (26% average weekly change). Earnings have declined by 27% per year over the past 5 years. Shareholders have been substantially diluted in the past year (39% increase in shares outstanding). Minor Risk Market cap is less than US$100m (US$29.1m market cap). New Risk • Dec 18
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 18% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 27% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (39% increase in shares outstanding). Market cap is less than US$100m (US$23.6m market cap). 공시 • Dec 17
NextPlat Corp (NasdaqCM:NXPL) announces an Equity Buyback for $2 million worth of its shares. NextPlat Corp (NasdaqCM:NXPL) announces a share repurchase program. Under the program, the company will repurchase up to $2 million of its outstanding common stock. 공시 • Dec 10
NextPlat Corp Updates Revenue Guidance for the Full Year of 2024 NextPlat Corp. updated revenue guidance for the full year of 2024. For the period, the company expects to report higher than expected annual 2024 revenue of approximately $63 million, an increase of over 70% compared to fiscal 2023 results. New Risk • Nov 24
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 39% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 27% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Shareholders have been diluted in the past year (39% increase in shares outstanding). Market cap is less than US$100m (US$24.4m market cap). 공시 • Nov 19
NextPlat Corp to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo NextPlat Corp. announced that it is participating in the 2024 China International Natural Health & Nutrition Expo (NHNE), Asia's largest exhibition focused on the sales and marketing of health, nutrition and dietary supplement products, as the Company continues to ramp-up sales and promotional activities in China. Held at the Wuhan International Expo Center from November 20th to the 22nd, the China International Natural Health & Nutrition expo is the premier exhibition focused on health, nutrition and dietary supplements. The bi-annual event is the largest of its kind in Asia with 1,200 suppliers from more than 30 countries and regions, attracting as many as 120,000 omnichannel buyers. At the event, an expanded array of products from OPKO Health Europe, a unit of OPKO Health Inc. (OPKO), including an initial selection of veterinary and animal care products will be on display for attendees. Additionally, NextPlat has also been invited by the U.S. Consulate General in Wuhan to present OPKO products during the NHNE expo to a specially selected group of Chinese buyers interested in U.S. healthcare products. As announced earlier this year, the Company has begun the sales of OPKO products in China and supported by a new in-country marketing partner, has recently engaged Chinese social media influencers and conducted experiential marketing programs. The Company is currently in the process of launching new online OPKO stores on leading digital sites in China including WeChat which has over 1.3 billion monthly users, and on JD.com, China's second largest e-commerce platform which attracts in excess of 560 million users annually. Additionally, the Company is seeking to secure physical distribution of OPKO products into major retail chains, pharmacies and grocery stores during 2025. OPKO is a global diversified diagnostic and pharmaceutical healthcare company with over 5,500 employees spanning nine countries. The distribution agreement with OPKO's European division represents the first relationship resulting from the Company's Florida E-commerce Development program which includes a merchant sourcing agreement with Alibaba's Tmall Global designed to provide American businesses with easy access to the Chinese consumer market. Reported Earnings • Nov 17
Third quarter 2024 earnings released: US$0.22 loss per share (vs US$0.18 profit in 3Q 2023) Third quarter 2024 results: US$0.22 loss per share (down from US$0.18 profit in 3Q 2023). Revenue: US$15.4m (flat on 3Q 2023). Net loss: US$4.22m (down 222% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings. New Risk • Nov 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 26% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (US$22.2m market cap). Board Change • Oct 27
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 independent directors. 6 non-independent directors. Independent Director Maria Fernandez was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. 공시 • Oct 07
NextPlat Corp Appoints Elizabeth Alcaine to the Board NextPlat Corp. (the “Company”) unanimously elected Ms. Elizabeth Alcaine to the Board to fill a vacancy in the Board effective as of October 1, 2024, and to serve until her successor shall have been duly elected and qualified or until her earlier resignation or removal. Ms. Alcaine, age 55, combines over 25 years of experience in the healthcare sector. Prior to joining the Board, Ms. Alcaine served as a member of the board of directors of Progressive Care Inc. She also currently serves as president of the Coral Coast HOA Board. In 2017, Ms. Alcaine became a co-founder of AskVetMD, a platform that makes veterinarians easily accessible, and remained until 2022. During 2023, she became a consultant for AskVetMD. From 2009 through 2018, Ms. Alcaine was an Advisory Committee member for the Miami Childrens Hospital Foundation. She has an undergraduate degree from Miami Dade College. Ms. Alcaine was appointed to the Board because of her extensive experience in the healthcare sector. 공시 • Oct 02
NextPlat Corp (NasdaqCM:NXPL) completed the acquisition of 58% stake in Progressive Care, Inc. (OTCPK:RXMD) from Charles M. Fernandez, Rodney Barreto and others. NextPlat Corp (NasdaqCM:NXPL) agreed to acquire 58% stake in Progressive Care, Inc. (OTCPK:RXMD) from Charles M. Fernandez, Rodney Barreto and others for $8 million on April 12, 2024. The following shall occur at the Effective Time: (a) each share of Company Common Stock that is issued and outstanding immediately prior to the Effective Time shall be cancelled and converted into the number of shares of Parent’s common stock, par value $0.0001 per share (the “ Parent Common Stock ”) as determined by the quotient obtained by dividing (i) $2.20, or the “ Company Per Share Value ”, by (ii) $1.48, or the “ Parent Per Share Value ” (which consideration shall be referred to as the “ Per Share Merger Consideration ”); (b) each share of Capital Stock held in the treasury of the Company shall be cancelled without any conversion thereof and no payment or distribution shall be made with respect thereto; (c) each Company Option that is outstanding immediately prior to the Effective Time shall be assumed by Parent and converted into an option to purchase shares of Parent Common Stock; (d) each Company Warrant that remains outstanding and unexercised immediately prior to the Effective Time shall automatically be converted into a warrant to purchase shares of Parent Common Stock; and (e) each Company RSU that is outstanding immediately prior to the Effective Time shall be assumed by Parent and converted into a restricted stock unit in respect of shares of Parent Common Stock.
The transaction is subject to subject to regulatory and stockholder approvals, and other customary closing conditions. The Closing is subject to certain conditions, including, among other things, (i) approval by the shareholders of the Company of the Merger, (ii) approval by the shareholders of Parent of the Merger, (iii) the Registration Statement being declared effective under the Securities Act, (iv) the Company’s delivery of officer’s certificate, and (v) Parent’s delivery of officer’s certificate, as well as all required filings under the HSR Act shall have been completed and any applicable waiting period (and any extension thereof) applicable to the consummation of the Transactions under the HSR Act shall have expired or been terminated. The transaction has been unanimously approved by the Board of Directors of both NextPlat and Progressive Care. Shareholders of Progressive Care approved the transaction on special meeting held on September 13, 2024. The transaction is expected to close in the third quarter of 2024. As of September 16, 2024, the transaction is expected to close on October 1, 2024. Ralph V. De Martino of ArentFox Schiff LLP served as the legal advisor to NextPlat and Scott Linskyof Lucosky Brookman LLP served as legal advisor to Progressive Care. Equity Stock Transfer acted as transfer agent to NextPlat. ClearTrust, LLC acted as transfer agent to Progressive Care.
NextPlat Corp (NasdaqCM:NXPL) completed the acquisition of 58% stake in Progressive Care, Inc. (OTCPK:RXMD) from Charles M. Fernandez, Rodney Barreto and others on October 1, 2024. 공시 • Sep 17
NextPlat Corp Approves Board Election NextPlat Corp. at its AGM held on September 13, 2024, approved to elect Jervis Hough and Anthony Armas as Board nominees to the company board, each to serve until the next annual meeting of stockholders of the company, or until such person’s successor is elected and qualified. Reported Earnings • Aug 15
Second quarter 2024 earnings released: US$0.28 loss per share (vs US$0.24 loss in 2Q 2023) Second quarter 2024 results: US$0.28 loss per share (further deteriorated from US$0.24 loss in 2Q 2023). Revenue: US$17.0m (up 475% from 2Q 2023). Net loss: US$5.31m (loss widened 22% from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 40% per year, which means it is significantly lagging earnings. 공시 • Aug 05
NextPlat Corp, Annual General Meeting, Sep 13, 2024 NextPlat Corp, Annual General Meeting, Sep 13, 2024. 공시 • Apr 14
NextPlat Corp (NasdaqCM:NXPL) agreed to acquire remaining minority stake in Progressive Care, Inc. (OTCPK:RXMD) from Charles M. Fernandez, Rodney Barreto and others. NextPlat Corp (NasdaqCM:NXPL) agreed to acquire remaining minority stake in Progressive Care, Inc. (OTCPK:RXMD) from Charles M. Fernandez, Rodney Barreto and others on April 12, 2024. The exchange ratio of NextPlat shares to be issued in the business combination, not subject to adjustment, was calculated based upon a 20-day, volume-weighted average price ("VWAP") of NextPlat's Common Stock preceding execution of the business combination agreement and a value per share of Common Stock of Progressive Care at $2.20. The exchange ratio was determined at a price per Common Share of Progressive Care above its 20-day VWAP on the date of execution and follows a comprehensive, independent, third-party valuation analysis conducted at the request of Progressive Care's special committee of independent directors. The transaction has been unanimously approved by the Board of Directors of both NextPlat and Progressive Care. The transaction is subject to subject to regulatory and stockholder approvals, and other customary closing conditions. The transaction is expected to close in the third quarter of 2024. ArentFox Schiff LLP served as the legal advisor to NextPlat and Lucosky Brookman LLP served as legal advisor to Progressive Care. 공시 • Apr 03
NextPlat Corp announced delayed annual 10-K filing On 04/02/2024, NextPlat Corp announced that they will be unable to file their next 10-K by the deadline required by the SEC. 공시 • Mar 26
NextPlat Corp (NasdaqCM:NXPL) agreed to acquire Outfitter Satellite, Inc. NextPlat Corp (NasdaqCM:NXPL) agreed to acquire Outfitter Satellite, Inc on March 26, 2024. The transaction is expected to close on April 1, 2024. 공시 • Feb 05
NextPlat Corp. Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China NextPlat Corp. is preparing for the launch of its exclusive OPKO Health-branded storefront on Alibaba Group Holding Limited's (Alibaba) Tmall Global in China following receipt of the initial set of approvals required to operate the store in the country. Under terms of the exclusive joint e-commerce development agreement with OPKO Health Europe, a subsidiary of OPKO Health Inc. secured late last year, NextPlat is launching an OPKO Health-branded online storefront on Alibaba's Tmall Global e-commerce platform in China. The new online storefront will initially list up to 40 health and wellness products featuring an assortment of nutraceuticals for bone, joint and eye health as well as supplements for nutrition and immunity and defense, the sales of which will create a new international e-commerce revenue stream for the Company. NextPlat intends to significantly expand the OPKO online storefront with a wide array of veterinary and animal health products, subject to final Chinese regulatory approval currently expected during the second quarter of 2024. All in-country sales and marketing support for the OPKO Health Tmall Global e-commerce site is being provided by a local online specialist, a Tmall Global-preferred merchant partner. The sales of OPKO products in China will be managed through NextPlat and will be made available to purchase for Chinese consumers through Tmall Global. Tmall Global is China's leading import e-commerce platform where consumers can access over 46,000 international brands. NextPlat's e-commerce development program, held in coordination with local Florida chambers of commerce, initially aims to help Florida-based businesses and manufacturers market and sell their products to potentially millions of new customers. The development program features NextPlat's turnkey global e-commerce solution and leverages the capabilities and reach of key partners including Alibaba and its Tmall Global platform, a premier B2C cross-border solution for global brands to reach Chinese consumers. NextPlat intends to expand this unique e-commerce development opportunity to businesses throughout the United States, North America as well as in Central and South America. Reported Earnings • Nov 17
Third quarter 2023 earnings released: EPS: US$0.18 (vs US$0.60 loss in 3Q 2022) Third quarter 2023 results: EPS: US$0.18 (up from US$0.60 loss in 3Q 2022). Revenue: US$15.3m (up 481% from 3Q 2022). Net income: US$3.45m (up US$9.16m from 3Q 2022). Profit margin: 23% (up from net loss in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 132% per year but the company’s share price has fallen by 55% per year, which means it is significantly lagging earnings. 공시 • Oct 15
NextPlat Corp.'s Florida E-Commerce Development Program to Launch the Online Sales of Opko Healthcare Products in China on Alibaba's Tmall Global NextPlat Corp. announced that through a new e-commerce distribution agreement, it will enable the online sales of OPKO Health Europe, a subsidiary of OPKO Health Inc. products in China. Under the terms of the agreement, NextPlat will launch a OPKO Health-branded online storefront on Alibaba Group Holding Limited's Tmall Global e-commerce platform in China featuring an assortment of nutraceutical and veterinary products sold and distributed by OPKO Europe. OPKO is a global diversified diagnostic and pharmaceutical healthcare company with over 5,500 employees spanning nine countries. The distribution agreement with OPKO's European division represents the first relationship resulting from the Company's Florida E-commerce Development program which includes a merchant sourcing agreement with Alibaba's Tmall Global designed to provide American businesses with easy access to the Chinese consumer market. The sales of OPKO products in China will be managed through NextPlat and will be made available to purchase for Chinese consumers through Tmall Global. Tmall Global is China's leading import e-commerce platform where consumers can access over 46,000 international brands. Subject to obtaining all necessary certifications and approvals, initial sales are expected to commence late in the fourth quarter of 2023. NextPlat's e-commerce development program, held in coordination with local Florida chambers of commerce, initially aims to help Florida-based businesses and manufacturers market and sell their products to potentially millions of new customers. The development program features NextPlat's turnkey global e-commerce solution and leverages the capabilities and reach of key partners including Alibaba and its Tmall Global platform, a premier B2C cross-border solution for global brands to reach Chinese consumers. NextPlat intends to expand this unique e-commerce development opportunity to businesses throughout the United States, North America as well as in Central and South America. Reported Earnings • Aug 14
Second quarter 2023 earnings released: US$0.24 loss per share (vs US$0.18 loss in 2Q 2022) Second quarter 2023 results: US$0.24 loss per share (further deteriorated from US$0.18 loss in 2Q 2022). Revenue: US$2.96m (up 3.0% from 2Q 2022). Net loss: US$4.34m (loss widened 162% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 112% per year but the company’s share price has fallen by 39% per year, which means it is significantly lagging earnings. Reported Earnings • May 21
First quarter 2023 earnings released: US$0.082 loss per share (vs US$0.093 loss in 1Q 2022) First quarter 2023 results: US$0.082 loss per share. Revenue: US$2.88m (down 20% from 1Q 2022). Net loss: US$1.19m (loss widened 40% from 1Q 2022). 공시 • Jan 06
NextPlat Corp, Annual General Meeting, Jun 29, 2023 NextPlat Corp, Annual General Meeting, Jun 29, 2023. 공시 • Dec 16
NextPlat Corp announced that it has received $8.007001 million in funding On December 14, 2022, NextPlat Corp closed the transaction. Reported Earnings • Nov 16
Third quarter 2022 earnings released: US$0.60 loss per share (vs US$0.37 loss in 3Q 2021) Third quarter 2022 results: US$0.60 loss per share (further deteriorated from US$0.37 loss in 3Q 2021). Revenue: US$2.63m (up 17% from 3Q 2021). Net loss: US$5.71m (loss widened 148% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 88% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings. Board Change • Nov 16
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 2 experienced directors. No highly experienced directors. President, CEO of Global Operations & Director David Phipps is the most experienced director on the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. 공시 • Sep 20
NextPlat Corp Appoint Cristina Fernandez to Board On September 13, 2022, the Board of Directors (the “Board”) of NextPlat Corp. (the “Company”) unanimously voted to increase the size of the Board from eight to nine directors, and to appoint Ms. Cristina Fernandez to fill the newly created Board position, to serve until her successor shall have been duly elected and qualified or until her earlier resignation or removal. Ms. Fernandez has extensive experience in achieving growth with new technologies, and motivating teams and customers in challenging business environments. She also has extensive international experience leading global and regional teams in the US, Latin America and Asia. Prior to joining us, Ms. Fernandez served as the Executive Vice President and Chief Operating Officer of eApeiron Solutions. Before that, Ms. Fernandez served as the Global Vice President/General Manager of Xerox Corporation’s Continuous Feed Inkjet Business. In addition, the Board approved a rotation in the membership of the Company’s audit committee, compensation committee and nominating committee. The membership of each such committee is now as follows: Audit Committee: Rodney Barreto (Committee Chair), Cristina Fernandez, and Lou Cusimano. Compensation Committee: Hector Delgado (Committee Chair), Lou Cusimano, and John Miller. Nominating Committee: Cristina Fernandez (Committee Chair), Lou Cusimano and Rodney Barreto. Reported Earnings • Aug 16
Second quarter 2022 earnings released: US$0.18 loss per share (vs US$0.59 loss in 2Q 2021) Second quarter 2022 results: US$0.18 loss per share. Revenue: US$2.87m (up 47% from 2Q 2021). Net loss: US$1.66m (loss widened 14% from 2Q 2021). Reported Earnings • May 18
First quarter 2022 earnings released: US$0.093 loss per share (vs US$0.81 loss in 1Q 2021) First quarter 2022 results: US$0.093 loss per share. Revenue: US$3.58m (up 145% from 1Q 2021). Net loss: US$850.1k (loss widened 5.8% from 1Q 2021). Board Change • Apr 27
High number of new directors There are 6 new directors who have joined the board in the last 3 years. Independent Director Rodney Barreto was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Apr 02
Full year 2021 earnings released: US$1.99 loss per share (vs US$10.32 loss in FY 2020) Full year 2021 results: US$1.99 loss per share. Revenue: US$7.74m (up 36% from FY 2020). Net loss: US$8.11m (loss widened 193% from FY 2020). 공시 • Jan 22
NextPlat Corp(NasdaqCM:NXPL) dropped from NASDAQ Composite Index Orbsat Corp. has been removed from NASDAQ Composite Index . 공시 • Jan 06
Orbsat Corp. announced that it has received $7.225038 million in funding On January 5, 2022, Orbsat Corp. closed the transaction. Reported Earnings • Nov 17
Third quarter 2021 earnings released: US$0.37 loss per share (vs US$7.12 loss in 3Q 2020) The company reported a mediocre third quarter result with increased losses and weaker control over costs, although revenues improved. Third quarter 2021 results: Revenue: US$2.25m (up 53% from 3Q 2020). Net loss: US$2.31m (loss widened 110% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has fallen by 45% per year, which means it is significantly lagging earnings. Board Change • Nov 17
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Chief Business Development Strategist & Vice Chairman Douglas Ellenoff was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. 공시 • Aug 18
Orbsat Corp. announced delayed 10-Q filing On 08/17/2021, Orbsat Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공시 • May 29
Orbsat Corp. has completed a Composite Units Offering in the amount of $14.4 million. Orbsat Corp. has completed a Composite Units Offering in the amount of $14.4 million.
Security Name: Units
Security Type: Equity/Derivative Unit
Securities Offered: 2,880,000
Price\Range: $5
Discount Per Security: $0.4 공시 • May 08
Orbsat Corp. Provides Earnings Guidance for the First Quarter Ended March 31, 2021 Orbsat Corp. announced earnings guidance for the first quarter ended March 31, 2021. For the quarter, Revenue is expected to be between $1.4 million and $1.5 million, representing a relatively unchanged amount from $1,468,103 for the same period in 2020. While the Company experienced a greater disruption resulting from the effects of the COVID-19 pandemic and the effects of Brexit in 2021 compared to 2020, the revenue remained primarily unchanged. Net loss for the quarter is expected to be between $0.7 million and $0.8 million, representing an increase from $284,860 for the same period in 2020. The increase is primarily due to an increase in professional fees related to the Company’s listing of its capital stock on a national securities exchange as well as the effects of noncash charges related to its convertible note payable. 공시 • Feb 11
Orbsat Corp Names Louis Wise to the Newly Created Position of Chief Technology Advisor Orbsat Corp. announced that it has named Louis Wise to the newly created position of Chief Technology Advisor. Drawing upon his 50-year career in satellite imaging and communications, military intelligence, and data collection and analysis, Mr. Wise will advise the Company on satellite communications and internet of things (IoT)-related sales as well as product development activities. Mr. Wise's role will assist the Company support its expanded focus on government and military markets through the recent launch of its new Orbsat Government unit. 공시 • Oct 20
Orbsat Corp. Appoints Thomas Seifert as Chief Financial Officer On October 14, 2020, the board of directors of Orbsat Corp. effected the following changes to the Company’s executive management: to appoint Thomas Seifert as the company’s Chief Financial Officer for a period of 12 months commencing on October 19, 2020. Prior to this appointment, Mr. Seifert has more than 20 years of general management, global operations and financial management expertise and has served as Chief Financial Officer for various public and private telecommunication companies during this period. Since January 2006 to present, Mr. Seifert has served as a principal of Rocky Mountain Advisors Corp. where he provides management and financial advisory services. 공시 • Aug 28
Orbsat Corp. announced that it has received $0.933 million in funding Orbital Tracking Corp. (OTCBB:TRKK) announced that it has entered into note purchase agreement for private placement of convertible promissory notes for gross proceeds of $933,000 on August 21, 2020. The notes are general, unsecured obligations and bear a simple interest rate of 6% per annum and would mature on August 20, 2023. In the event that any amount due under the Notes is not paid as and when due, such amounts will accrue interest at the rate of 12% per year, simple interest, non-compounding, until paid. The company may not pre-pay or redeem the notes other than as required by the agreement. The note holders have an optional right of conversion such that a noteholder may elect to convert his note, in whole or in part, outstanding as of such time, into the number of fully paid and non-assessable shares of the company’s common stock as determined by dividing the outstanding indebtedness by $0.20, subject to certain adjustments. This optional right of conversion is subject to a beneficial ownership limitation of 9.99% of the number of shares of the company’s common stock outstanding immediately after giving effect to the share issuance upon conversion. The holders of the notes are granted demand registration rights and pre-emptive rights. In addition, the agreement includes customary events of default, including, non-payment of amounts due thereunder, non-compliance with covenants thereunder, bankruptcy or insolvency. Upon the occurrence of an event of default, a majority of the holders may accelerate the maturity of the Indebtedness. The securities were issued pursuant to exemption provided under Rule 506 of Regulation D. 